These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the risks that are discussed more fully in our filings with the Securities and Exchange Commission (the SEC) including the Risk Factors section of our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 24, 2026, and other documents we subsequently file with or furnish to the SEC, including our Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the SEC on May 12, 2026
This opens promising avenues for developing transgenic plants with enhanced resistance and stable productivity under challenging environmental conditions
The orforglipron story reminds us that behind every breakthrough medication lies not just laboratory experimentation but sophisticated computational approaches that predict, optimize, and validate therapeutic potential
Insert the needle, inject the solution slowly, withdraw the needle, and release the skin
Food Bioactives and Nutraceuticals: Dietary Medicine for Human Health and Well-being
12 All except one were published in English and we used translated version for data verification